FDA Investigator Dr. Guang Gao, PhD
Dr. Guang Gao, PhD has conducted inspections on 15 sites in 2 countries as of 09 Nov 2017. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
09 Nov 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
United States of America
FDA Investigators that have inspected at least one site in common with Dr. Guang Gao, PhD:
Abdur Razzaque,
Ademola O Daramola,
Alicia M Mozzachio,
Allen F Hall,
Amanda Dinaro,
Amanda S Zorn,
Amy M Cramer,
Angela E Glenn,
Anh M Lac,
Ann Marie Montemurro,
Anna Flynn,
Arie C Menachem,
Arsen Karapetyan,
Atul J Agrawal,
Bonita S Chester,
Brenda L Reihing,
Brentley S Collins,
Brian D Nicholson,
Bruce H Mccullough,
Bryce E Mansfield,
Burnell M Henry,
Carrie Ann Plucinski,
Catherine J Laufmann,
Chad E Schmear,
Charles I Ann,
Charles L Larson,
Cheryl A Clausen,
Chiang Syin, PhD,
Christian D Lynch (CDL),
Christina V Santos,
Christine M Parmentier,
Christopher T Middendorf,
Cody D Rickman,
Creighton T Tuzon,
Cynthia Jim, CSO,
Daniel C Kearns,
Daniel J Roberts,
Daniel Kearns,
Daniel T Lee,
Dannie E Rowland,
Deborah A Nebenzahl,
Debra I Love,
Debra Lboyd Seale,
Dolores E Price,
Dolores Harper,
Dr. Ralph M Bernstein, PhD,
Edwin Melendez,
Eileen A Liu,
Elliot P Cowam, PhD,
Eric J Cunningham,
Eric M Mueller, PharmD,
Erin L Mcfiren,
Farhana Khan,
Felix Maldonado,
Finn A Slizza,
Francis A Guidry,
Frank J Marciniak,
Gene D Arcy,
Helen B Ricalde,
Henry K Lau,
Humera T Khan,
Ivis L Negron,
Jacob M Dyer,
Jacqueline Mdiaz Albertini,
James A Lane,
James R Montero,
James W Plucinski,
Jan B Welch,
Jason F Chancey,
Jean M Kelahan,
Jeanne M Morris,
Jeffrey M Watson,
Jenny L Chisem,
Jenny L Mccardell,
Jesse A Vazquez,
Joan A Loreng,
Jose R Hernandez,
Joseph A Morkunas,
Joseph R Strelnik,
Jude C Dikes,
Julie D Bringger,
Karen Emasley Joseph,
Kathleen B Swat,
Kevin A Gonzalez,
Kevin P Foley,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Kujtim Sadiku,
Lakisha M Williams,
Lance Mde Souza, MBA,
Lauren L Vajo,
Lauren M Lilly, PhD,
Laurie A Haxel,
Leonard H Lavi,
Lequita M Mayhew,
Li Li,
Linda Thai,
Lisa Hornback,
Lorelei S Jarrell,
Loretta Nemchik,
Lori J Silverstein,
Lori Peters,
Lori S Lawless,
Lydia S Chan,
Margaret Torres Vazquez,
Marie F Morin,
Mariza M Jafary,
Martha T Olone,
Maureen C Melvin,
Mei Chiung Huang (Jo),
Michael A Charles,
Michael D Robinson,
Mihaly S Ligmond,
Nancy A Saxenian Emmons,
Nicholas F Lyons,
Nicole J Clausen,
Nicole K Trudel,
Nicole S Williams,
Nisha C Patel,
Norman Wong,
Omotunde O Osunsanmi,
Patricia D Gardner,
Paul M Kawamoto,
Paula A Trost,
Peter E Baker,
Philip E Ake,
Prabhu P Raju,
Qiao Y Bobo,
Qin Xu,
Rafael Padilla,
Ralph A Erickson,
Rebecca Rodriguez,
Rebecca T Davis,
Richard T Riggie,
Robert L Stevenson,
Roberta W Cunningham,
Rocco C Black,
Ronald T Nowalk,
Rose Ashley,
Russell K Riley,
S Lori Brown, PhD MPH,
Sara Jdent Acosta,
Sarah B Tanksley,
Sarah Forney,
Scott K Zika,
Sharon I Gundersen,
Simone E Pitts,
Stephen D Eich,
Steven P Donald,
Susan A Zullo, PhD,
Susan M Jackson,
Susan W Ting,
Tamara Brey,
Tamil Arasu, PhD,
Tammy L Chavis,
Thomas Cosgrove,
Todd M Stankewicz,
Tonia F Bernard,
Uros V Djekic, PhD,
Xiaojun Yan,
Yvette E Guillermo,
Zi Qiang Gu
Dr. Guang Gao, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2016 | FDA 483 | Yancheng Youhua Pharmaceutical and Chemical Technology Co. Ltd - Form 483, 2016-03-25 |
| April, 2014 | FDA 483 | Bio-Rad Laboratories, Inc. - Form 483, 2014-04-23 |
| August, 2015 | FDA 483 | Zhejiang Hisoar Pharmaceutical Co., Ltd. - Form 483, 2015-08-13 |
| April, 2015 | FDA 483 | Maxim Biomedical Inc. - Form 483, 2015-04-15 |
| June, 2015 | FDA 483 | Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory - Form 483, 2015-06-18 |
| February, 2016 | FDA 483 | Yunnan Hande Bio-Tech Co., Ltd. - Form 483, 2016-02-26 |
| July, 2015 | FDA 483 | Changzhou Ruiming Pharmaceutical Co.,Ltd. - Form 483, 2015-07-17 |
| May, 2012 | FDA 483 | Novartis Diagnostics - Form 483, 2012-05-09 |
| May, 2012 | EIR | Grifols Diagnostic Solutions Inc. - EIR, 2012-05-09 |
| September, 2015 | FDA 483 | BrightGene Pharmaceutical Co., Ltd. - Form 483, 2015-09-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more